Chemotherapy Induced Acral Erythema (Hand Foot syndrome) Treatment Market, By Product (Analgesics, Anti-Inflammatory& Anti-Edematous Agents, Antihistaminic, NSAIDS, Oral/Topical Glucocorticoids, Pyridoxine(Vitamin B6) and Others (Cold compression, therapy, emollients)),By Severity (Grade1, Grade2, Grade3, Grade4), By End-User (Diagnostics and Research, Pharmacy and Drugstores), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2034

Report Code: PMI462321 | Publish Date: May 2024 | No. of Pages: 168

Global Chemotherapy Induced Acral Erythema Treatment Market Overview

Acral Erythema, also known as hand-foot syndrome or palmar-plantar erythrodysesthesia is caused when small amounts of chemotherapy drugs leak out of these capillaries affecting the skin on the hands and feet and characterized by swelling, redness, paresthesia(numbness), desquamation of palms or soles. Onychlolysis (lifting of nails) is associated with severe reactions, the skin may thicken and skin color gets even darker. Although it doesn’t cause any harm, hand-foot syndrome certainly affects the quality of lifestyle and is often a dose-limiting side effect. Acryl erythema drug has adverse effect that are typically visible after several months of chemotherapeutics, gemcitabine, and fluorouracil. Diagnosis can be done through skin biopsy, which may show a variable degree of scattered individual skin cell death, inflammation at the junction of the epidermis and dermis and opening up of blood vessels. Use of a hand/foot moisturizer before starting chemotherapy is recommended. Avoiding mechanical trauma to hands, feet and all body skin such as friction, heat, pressure and adhesives may help limit the reaction. This includes wearing loose-fitting comfortable clothing, which avoids tight pressure or rubbing. Cooling of the hands and feet during chemotherapy administration had variable success in preventing any skin irritation. When the reaction has developed, analgesics, cold compresses and elevation or cushioning of the affected parts may give some relief to the sufferers.

Global Chemotherapy Induced Acral Erythema Treatment Market Dynamics

Increasing incidence of cancers

Surge in usage of therapeutic drugs due to increase in cancer patients mainly drives the global chemotherapy induced acral erythema (hand-foot syndrome) treatment market. According to the WHO cancer factsheet 2018, cancer is the second leading cause of death globally. It was estimated that 9.6 million deaths or one in six death occurred due to this reason. Moreover, increasing number of smokers, life up-gradation are some secondary reasons for the growth of global chemotherapy induced acral erythema (hand-foot syndrome) treatment market.

Emerging new inventions of some drugs and new therapies

Some drugs and new technologies are coming up for the treatment of chemotherapy induced acral erythema (hand-foot syndrome) like topical sildenafil, nicotine patches, topical allopurinol and others which will boost the market.

Global Chemotherapy Induced Acral Erythema Treatment Market Segmentation

On the basis of product, the Chemotherapy Induced Acral Erythema (Hand Foot syndrome) Treatment Market is segmented into Analgesics, Analgesics, Anti-Inflammatory & Anti-Edematous Agents, Antihistaminic, NSAIDS, Oral/Topical Glucocorticoids, Pyridoxine (Vitamin B6) and Others (Cold compression, therapy, and emollients). Based on site of severity, the target market is segmented into Grade1 (Dysesthesia/paresthesia, tingling in hands and feet), Grade2 (Discomfort in walking and/or in holding objects, painless swelling, redness), Grade3 (Painful swelling and redness in palms and soles, and around fingernails and toenails), Grade4 (Scaling, ulceration, blistering, severe pain). On the basis of end-use, the target market is segmented into Diagnostics and Research, Pharmacy and Drugstores.

Regional Insights:

On the basis of region, the Chemotherapy Induced Acral Erythema (Hand Foot syndrome) Treatment Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Being first line surgery of acryl erythema, analgesics segment is expected to contribute for major portion in global chemotherapy induced acral erythema treatment market. Valencia institute studied that 2% incidence of chemotherapy induced acral erythema among cancer patient who are treated with chemotherapy in Europe. North America contributes a major share in the Global chemotherapy induced acral erythema (hand foot syndrome) treatment market owing to more usage of gemcitabine, a major cause of this syndrome.

Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2030

Market Segmentation

By Product- Analgesics, Anti-Inflammatory& Anti-Edematous Agents, Antihistaminic, NSAIDS, Oral/Topical Glucocorticoids, Pyridoxine(Vitamin B6) and Others (Cold compression, therapy, emollients).

By Severity– Grade1 (Dysesthesia/paresthesia, tingling in hands and feet), Grade2 (Discomfort in walking and/or in holding objects, painless swelling, redness), Grade3 (Painful swelling and redness in palms and soles, and around fingernails and toenails), Grade4 (Scaling, ulceration, blistering, severe pain).

By End-use- Diagnostics and Research, Pharmacy and Drugstores

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented Chemotherapy Induced Acral Erythema (Hand Foot syndrome) Treatment Market report based on product, severity, end-use, and region.

Chemotherapy Induced Acral Erythema (Hand Foot syndrome) Treatment Market Segmentation

Covid-19 Sample Collection Kits Market, By Region:

  • North America
    • Middle East & Africa
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa
    • Latin America
        • Brazil
        • Mexico
        • Rest of Latin America
    • Asia Pacific
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Europe
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
      • U.S.
      • Canada

Global Chemotherapy Induced Acral Erythema Treatment Market Key Players

The key players operating in the chemotherapy induced acral erythema (hand-foot syndrome) market include Taro Pharmaceuticals Inc., Oceanside Pharmaceuticals, Pfizer, Novartis, A-S Medication Solutions, Preferred Pharmaceuticals, Syntex Pharmaceuticals, Valeant Canada, Techni lab Pharma, Allergen.

Global Chemotherapy Induced Acral Erythema Treatment Market Company Profile

  • Pfizer
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Taro Pharmaceuticals Inc.
  • Oceanside Pharmaceuticals
  • Novartis
  • A-S Medication Solutions
  • Preferred Pharmaceuticals
  • Syntex Pharmaceuticals
  • Valeant Canada
  • Techni lab Pharma
  • Allergen

 “*” marked represents similar segmentation in other categories in the respective section.

Global Chemotherapy Induced Acral Erythema Treatment Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Preview
    • Executive Summary
    • Key Findings—Global Outlook for  Chemotherapy Induced Acral Erythema (Hand Foot syndrome) Treatment Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Product
      • Market Snippet, By severity
      • Market Snippet, By End-user
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Market Segmentation, By Product, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Analgesics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Anti-inflammatory & Anti-edematous agents
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Antihistaminic
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • NSAIDS
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Oral/Topical Glucocorticoids
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Pyridoxine(Vitamin B6)
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Market Segmentation, By Severity, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Grade1
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Grade2
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Grade3
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Grade4
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Market Segmentation, By End-user, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Diagnostics and research
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Pharmacy and Drugstore
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Severity, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Severity, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Severity, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Severity, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Severity, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  10. Company Profiles
  • Pfizer
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Taro Pharmaceuticals Inc.
  • Oceanside Pharmaceuticals
  • Novartis
  • A-S Medication Solutions
  • Preferred Pharmaceuticals
  • Syntex Pharmaceuticals
  • Valeant Canada
  • Techni lab Pharma
  • Allergen

The Last Word

  • Future Impact
  • About Us
  • Contact

FAQs

Global Chemotherapy Induced Acral Erythema (Hand Foot syndrome) Treatment Market is segmented based on product, severity, end-use, and region.

Rising prevalence of cancer patients is the major factor driving growth of the Global Chemotherapy Included Acral Erythema (hand foot syndrome) Treatment Market.

North America is expected to lead the market owing to the increasing usage of gemcitabine, a major cause of this syndrome.